Wisderm.com
Open menu
Concerns
Interventions
Latest Research
FAQ
Effect of Hydroquinone + Tretinoin + Corticosteroid on Irritation
Side Effect
Study
Year
Effect
Description
Study Outcomes
Efficacy and safety of a novel triple combination cream compared to Kligman's trio for melasma: A 24-week double-blind prospective randomized controlled trial
2023
🠩
Sign in to read for free
Efficacy and safety of a novel triple combination cream compared to Kligman's trio for melasma: A 24-week double-blind prospective randomized controlled trial
Sign in to read for free
Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman's formula) in treating melasma: A randomized controlled study
2022
🠩
Sign in to read for free
Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman's formula) in treating melasma: A randomized controlled study
Sign in to read for free
Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity
2012
🠩
Sign in to read for free
Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity
Sign in to read for free
Instrumental analysis of the pattern of improvement and that of recurrence of melasma in Thai females treated with Kligman-Willis triple combination therapy: confirmation by using its two different formulae
2011
🠩
Sign in to read for free
Instrumental analysis of the pattern of improvement and that of recurrence of melasma in Thai females treated with Kligman-Willis triple combination therapy: confirmation by using its two different formulae
Sign in to read for free
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma
2008
🠩
Sign in to read for free
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma
Sign in to read for free
Community-based trial of a triple-combination agent for the treatment of facial melasma
2006
🠩
Sign in to read for free
Community-based trial of a triple-combination agent for the treatment of facial melasma
Sign in to read for free
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma
2005
🠩
Sign in to read for free
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma
Sign in to read for free
A double-blind randomised controlled trial - the gold standard
A human study that doesn't meet the gold standard
A case report or a study conducted on animals, tissues, or cells
Latest Research
Efficacy and safety of a novel triple combination cream compared to Kligman's trio for melasma: A 24-week double-blind prospective randomized controlled trial (2023)
See study outcomes
Sign in to read for free
Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman's formula) in treating melasma: A randomized controlled study (2022)
See study outcomes
Sign in to read for free
Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity (2012)
See study outcomes
Sign in to read for free
Instrumental analysis of the pattern of improvement and that of recurrence of melasma in Thai females treated with Kligman-Willis triple combination therapy: confirmation by using its two different formulae (2011)
See study outcomes
Sign in to read for free
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma (2008)
See study outcomes
Sign in to read for free
Community-based trial of a triple-combination agent for the treatment of facial melasma (2006)
See study outcomes
Sign in to read for free
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma (2005)
See study outcomes
Sign in to read for free